Given extensive evidence for the transcriptional makeup of MG being determined by the local CNS environment (Gosselin et al., 2017), we reasoned that evaluating MG responses following 3-wk differentiation and expansion in culture may underestimate the impact of treatments, of GRIP1 deletion, or both on MG biology. Here, GRIP1 is linked to myasthenia gravis.